Aarey Drugs & Pharmaceuticals Limited (BOM:524412)

BOM:524412 Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	40.24	46.84	37.71	65.55	65.14
Depreciation & Amortization	19.45	16.98	15.74	19.88	9.2
Other Operating Activities	48.34	30.44	28.27	18.82	25.55
Change in Accounts Receivable	509.96	53.02	-534.97	257.29	-658.79
Change in Inventory	-108.05	-58.57	-151.35	47.77	-14.65
Change in Accounts Payable	-264.02	16.12	176.7	-6.78	325.9
Change in Income Taxes	0.77	-4.58	-8.24	9.43	-
Change in Other Net Operating Assets	-143.68	-130.18	423.33	-406.97	302.41
Operating Cash Flow	103	-29.94	-12.81	4.99	54.77
Operating Cash Flow Growth	-	-	-	-90.89%	91.69%
Capital Expenditures	-52.04	-7.22	-10.44	-22.01	-28.79
Sale of Property, Plant & Equipment	-	-	-	0.05	-
Investment in Securities	-7.35	-9.8	14.85	-23.89	-
Other Investing Activities	-	-	-	13.75	-
Investing Cash Flow	-59.39	-17.02	4.41	-32.1	-28.79
Long-Term Debt Issued	-	-	10.21	-	-
Long-Term Debt Repaid	-12.38	-11.36	-	-	-0.19
Net Debt Issued (Repaid)	-12.38	-11.36	10.21	-	-0.19
Issuance of Common Stock	16.51	105.14	-	82.32	-
Other Financing Activities	-48.95	-37.93	3.33	-59.79	-24.32
Financing Cash Flow	-44.82	55.85	13.54	22.53	-24.51
Miscellaneous Cash Flow Adjustments	-	-0	-0	-	-
Net Cash Flow	-1.21	8.89	5.14	-4.58	1.47
Free Cash Flow	50.96	-37.16	-23.25	-17.03	25.98
Free Cash Flow Growth	-	-	-	-	33.99%
Free Cash Flow Margin	1.07%	-0.92%	-0.56%	-0.34%	0.74%
Free Cash Flow Per Share	1.80	-1.46	-0.91	-0.71	1.11
Cash Interest Paid	35.42	41.95	25.4	19.1	23.18
Cash Income Tax Paid	19.09	13.25	22.79	35.9	16.64
Levered Free Cash Flow	-157.35	-21.19	-288.63	71.5	-47.73
Unlevered Free Cash Flow	-135.21	5.03	-272.75	82.83	-33.24
Change in Working Capital	-5.02	-124.19	-94.53	-99.27	-45.12

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.